IQVIA Holdings Inc. IQV

270.37 (4.65) (1.69%) as of 25 Sep
Market cap
$45.3B
P/E
33.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

IQVIA Holdings Inc. (IQV) P/S ratio

As of 25 September 2026, IQVIA Holdings Inc. (IQV) trades at a P/S ratio of 2.6×. Over the past ten years it has ranged from 1.2× (February 2016) to 4.0× (December 2021); the current reading is higher than 64% of that period. That is below the Diagnostics & Research industry median of 4.9× and below the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 2.4× 2.72%
FY2024 2.3× (18.17%)
FY2023 2.8× 6.48%
FY2022 2.7× (31.81%)
FY2021 3.9× 28.99%
FY2020 3.0× 10.99%
FY2019 2.7× 19.62%
FY2018 2.3× 1.48%
FY2017 2.2× 33.06%
FY2016 1.7× 14.33%

Quarterly

Period P/S ratio Change
Jun 2026 1.9× 9.45%
Mar 2026 1.7× (27.32%)
Dec 2025 2.4× 16.87%
Sep 2025 2.0× 17.87%
42 more quarters

Against its own ten years

Low 1.2× High 4.0×
Ten-year median 2.5×
Current reading's percentile 64

P/S ratio against peers

Company P/S ratio
DGX Quest Diagnostics Incorporated compare 2.3×
IQV IQVIA Holdings Inc. 2.6×
A Agilent Technologies, Inc. compare 6.6×
MTD Mettler-Toledo International, Inc. compare 7.4×
IDXX IDEXX Laboratories, Inc. compare 9.0×
ILMN Illumina, Inc. compare 9.2×
WAT Waters Corporation compare 9.2×
GH Guardant Health, Inc. compare 19.9×
NTRA Natera, Inc. compare 21.8×
Diagnostics & Research industry median 4.9×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on IQV